Six members of the Alliance for Pulmonary Hypertension team—Ioanna Alysandratou, Pisana Ferrari, Mélanie Gallant-Dewavrin, Louise Bouman van der Waal, Hans-Dieter Kulla, and Laure Rosé—attended the 7th World Symposium on Pulmonary Hypertension. The event was both exciting and enriching, offering the privilege of networking with leading medical experts whose innovative work is driving new treatments and

The Alliance for Pulmonary Hypertension team – Ioanna Alysandratou, Pisana Ferrari, Mélanie Gallant-Dewavrin, Louise Bouman – van der Waal, Hans-Dieter Kulla and Laure Rosé – is back from the 7th World Symposium on Pulmonary Hypertension in Barcelona. Attending the World Symposium on Pulmonary Hypertension was an incredibly exciting and enriching experience. The scientific sessions were

In his concluding remarks at the 7th World Symposium on Pulmonary Hypertension, Prof. Marc Humbert highlighted the impressive diversity and scale of the event. The symposium hosted 1,697 participants, including 1,102 healthcare professionals, from various specialties, 124 task force members, and 471 industry staff, from over 60 countries. This diversity underscores the global effort and

The Alliance for Pulmonary Hypertension will have six delegates attending the World Symposium on Pulmonary Hypertension taking place in Barcelona 29.6-1.7 2024. Visit their booth and meet the team! Ioanna Alysandratou Ιωάννα Αλυσανδράτου President of the Hellenic Community for Pulmonary Hypertension Louise Bouman – van der Waal Chair of the Stichting Pulmonale Hypertensie / PH

The first John Vane Memorial Symposium on Prostacyclin Science and Pulmonary Vascular Disease was held in London, UK, 2006 to honour the memory of Sir John Vane, the founder of the William Harvey Research Institute and Nobel prize Laureate for his discovery of prostacyclin and its analogues (see also our article at this link). It